Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia

Schizophrenia Research

Volumn 68, Issue 1, 2004, Pages 37-48

  Lencz, Todd ^a,b,c   Smith, Christopher W ^a,b   Auther, Andrea ^a,b   Correll, Christoph U ^a,b   Cornblatt, Barbara ^a,b,c  

^a Recognition and Prevention Program   (United States)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Clinical high risk; Co morbidity; Negative symptoms; Nonspecific symptoms; Prodromal; Social isolation

Indexed keywords

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENUATION; AVOIDANT PERSONALITY DISORDER; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISORIENTATION; HIGH RISK PATIENT; HUMAN; MAJOR DEPRESSION; MENTAL PATIENT; NEGATIVE SYNDROME; PARENT; PERSONALITY DISORDER; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC TEST; PSYCHOSIS; RATING SCALE; SCHIZOPHRENIA; SOCIAL ISOLATION;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMORBIDITY; DEPRESSION; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; OBSERVER VARIATION; PSYCHOTIC DISORDERS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ISOLATION;

EID: 1642323732     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(03)00214-7     Document Type: Article

References (47)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;APA Press, Washington, DC.
2. Cannon M., Walsh E., Hollis C., Kargin M., Taylor E., Murray R.M., Jones P.B. Predictors of later schizophrenia and affective psychosis among attendees at a child psychiatry department. Br. J. Psychiatry. 178:2001;420-426.
3. Cannon M., Caspi A., Moffitt T.E., Harrington H., Taylor A., Murray R.M., Poulton R. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch. Gen. Psychiatry. 59:2002;449-456.
4. Cardno A.G., Thomas K., McGuffin P. Clinical variables and genetic loading in schizophrenia: analysis of published Danish adoption study data. Schizophr. Bull. 28:2002;393-399.
5. Cornblatt B.A. From the prediction of schizophrenia to prevention: New York high risk project to the hillside Recognition and Prevention (RAP) Program. Am. J. Med. Genet. Part B: Neuropsychiatric Genet. 114:2002;956-966.
6. Cornblatt B.A., Keilp J.G. Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr. Bull. 20:1994;31-46.
7. Cornblatt B.A., Obuchowski M., Schnur D., O'Brien J.D. Hillside study of risk and early detection in schizophrenia. Br. J. Psychiatry, Suppl. 172:1998;26-32.
8. Cornblatt B.A., Obuchowski M., Roberts S., Pollack S., Erlenmeyer-Kimling L. Cognitive and behavioral precursors of schizophrenia. Dev. Psychopathol. 11:1999;487-508.
9. Cornblatt B.A., Lencz T., Obuchowski M. The schizophrenia prodrome: treatment and high-risk perspectives. Schizophr. Res. 54:2002;177-186.
10. Cornblatt B.A., Lencz T., Smith C.W., Correll C.U., Auther A., Nakayama E. The schizophrenia prodome revisited: A neurodevelopmental perspective. Schizophr. Bull. 19:2003;. in press.
11. Davidson M., Reichenberg A., Rabinowitz J., Weiser M., Kaplan Z., Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am. J. Psychiatry. 156:1999;1328-1335.
12. Dworkin R.H., Bernstein G., Kaplanski L.M., Lipsitz J.D., Rinaldi A., Slater S.L., Cornblatt B., Erlenmeyer-Kimling L. Social competence and positive and negative symptoms: a longitudinal study of children and adolescents at risk for schizophrenia and affective disorder. Am. J. Psychiatry. 148:1991;1182-1188.
13. Dworkin R.H., Cornblatt B., Friedmann R., Kaplanski L.M., Lewis J.A., Rinaldi A., Shilliday C., Erelemeyer-Kimling L. Childhood precursors of affective vs. social deficits in adolescents at risk for schizophrenia. Schizophr. Bull. 1993;563-577.
14. Faraone S.V., Green A.I., Seidman L.J., Tsuang M.T. " Schizotaxia": clinical implications and new directions for research. Schizophr. Bull. 27:2001;1-18.
15. Fenton W.S., McGlashan T.H. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. Am. J. Psychiatry. 151:1994;351-356.
16. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr. Bull. 26:2000;119-136.
17. Hafner H., an der Heiden W. The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies. Eur. Arch. Psychiatry Clin. Neurosci. 249(Suppl. 4):1999;14-26.
18. Hollingshead A.B. Two Factor Index of Social Position. 1957;Yale University, New Haven.
19. Jones P.B., Done D.J. From birth to onset: a developmental perspective of schizophrenia in two national birth cohorts. Keshavan M.S., Murray R.M. Neurodevelopment and Adult Psychopathology. 1997;119-136 Cambridge Univ. Press, Cambridge.
20. Jones P.B., Tarrant C.J. Specificity of developmental precursors to schizophrenia and affective disorders. Schizophr. Res. 39:1999;121-125.
21. Jones P., Rodgers B., Murray R., Marmot M. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 344:1994;1398-1402.
22. Lencz T., Raine A. Schizotypal personality: synthesis and future directions. Raine A., Lencz T., Mednick S.A. Schizotypal Personality. 1995;429-459 Cambridge Univ. Press, Cambridge.
23. Lencz T., Cornblatt B., Bilder R.M. Neurodevelopmental models of schizophrenia: pathophysiologic synthesis and directions for intervention research. Psychopharmacol. Bull. 35:2001;95-125.
24. Maziade M., Roy M.A., Fournier J.P., Cliche D., Merette C., Caron C., Garneau Y., Montgrain N., Shriqui C., Dion C.et al. Reliability of best-estimate diagnosis in genetic linkage studies of major psychoses: results from the Quebec pedigree studies. Am. J. Psychiatry. 149:1992;1674-1686.
25. McGlashan T.H., Miller T.J., Woods S.W., Hoffman R.E., Davidson L. Instrument for the assessment of prodromal symptoms and states. Miller T.J., Mednick S.A., McGlashan T.H., Libiger J., Johannessen J.O. Early Intervention in Psychotic Disorders. 2001;135-149 Kluwer Academic Publishing, Dordrecht.
26. McGlashan T.H., Miller T.J., Woods S.W. Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. Schizophr. Bull. 27:2001;563-570.
27. McGorry P.D., Yung A.R., Phillips L.J., Yuen H.P., Francey S., Cosgrave E.M., Germano D., Bravin J., McDonald T., Blair A., Adlard S., Jackson H. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry. 59:2002;921-928.
28. Meehl P.E. Schizotaxia, schizotypy, schizophrenia. Am. Psychol. 17:1962;827-838.
29. Meehl P.E. Schizotaxia revisited. Arch. Gen. Psychiatry. 46:1989;935-944.
30. Miller T.J., McGlashan T.H., Woods S.W., Stein K., Driesen N., Corcoran C.M., Hoffman R., Davidson L. Symptom assessment in schizophrenic prodromal states. Psychiatr. Q. 70:1999;273-287.
31. Miller T.J., McGlashan T.H., Rosen J.L., Somjee L., Markovich P.J., Stein K., Woods S.W. Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of interrater reliability and predictive validity. Am. J. Psychiatry. 159:2002;863-865.
32. Miller T.J., Zipursky R.B., Perkins D., Addington J., Woods S.W., Hawkins K.A., Hoffman R., Preda A., Epstein I., Addington D., Lindborg S., Marquez E., Tohen M., Breier A., McGlashan T.H. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: II. Baseline characteristics of the "prodromal" sample. Schizophr. Res. 61:2003;19-30.
33. Olin S.C., Mednick S.A. Risk factors of psychosis: identifying vulnerable populations premorbidly. Schizophr. Bull. 22:1996;223-240.
34. Olin S.C., Mednick S.A., Cannon T., Jacobsen B., Parnas J., Schulsinger F., Schulsinger H. School teacher ratings predictive of psychiatric outcome 25 years later. Br. J. Psychiatry, Suppl. 172:1998;7-13.
35. Orvaschel H., Puig-Antich J. Schedule for Affective Disorders and Schizophrenia for School-Age Children - Epidemiologic Version. 1994;Ctr for Psychological Studies, Nova Southeastern Univ. Fort Lauderdale, FL.
36. Pfohl B., Blum N., Zimmerman M. Structured Interview for DSM-IV Personality (SIDP-IV). 1995;Department of Psychiatry, University of Iowa, Iowa City.
37. Phillips L.J., Yung A.R., McGorry P.D. Identification of young people at risk of psychosis: validation of personal assessment and crisis evaluation clinic intake criteria. Aust. N. Z. J. Psychiatry. 34:2000;S164-S169. (Supplement).
38. Siever L.J., Silverman J.M., Horvath T.B., Klar H., Coccaro E., Keefe R.S., Pinkham L., Rinaldi P., Mohs R.C., Davis K.L. Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients. Arch. Gen. Psychiatry. 47:1990;634-640.
39. Siever L.J., Kalus O.F., Keefe R.S. The boundaries of schizophrenia. Psychiatr. Clin. North Am. 16:1993;217-244.
40. Tsuang M.T., Stone W.S., Faraone S.V. Toward reformulating the diagnosis of schizophrenia. Am. J. Psychiatry. 157:2000;1041-1050.
41. Tsuang M.T., Stone W.S., Tarbox S.I., Faraone S.V. An integration of schizophrenia with schizotypy: identification of schizotaxia and implications for research on treatment and prevention. Schizophr. Res. 54:2002;169-175.
42. Weiser M., Reichenberg A., Rabinowitz J., Kaplan Z., Mark M., Bodner E., Nahon D., Davidson M. Association between nonpsychotic psychiatric diagnoses in adolescent males and subsequent onset of schizophrenia. Arch. Gen. Psychiatry. 58:2001;959-964.
43. Weissman M.M., Wickramaratne P., Adams P.B., Lish J.D., Horwath E., Charney D., Woods S.W., Leeman E., Frosch E. The relationship between panic disorder and major depression. A new family study. Arch. Gen. Psychiatry. 50:1993;767-780.
44. Yung A.R., McGorry P.D. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr. Bull. 22:1996;353-370.
45. Yung A.R., McGorry P.D. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust. N. Z. J. Psychiatry. 30:1996;587-599.
46. Yung A.R., McGorry P.D., McFarlane C.A., Jackson H.J., Patton G.C., Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr. Bull. 22:1996;283-303.
47. Yung A.R., Phillips L.J., McGorry P.D., McFarlane C.A., Francey S., Harrigan S., Patton G.C., Jackson H.J. Prediction of psychosis: a step towards indicated prevention of schizophrenia. Br. J. Psychiatry, Suppl. 172:1998;14-20.